Epidemiology and Treatment of Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Infections
Year: 2019
Type: article
Abstract: , especially strains with certain specific mechanisms of resistance. A section is devoted to reviewing upcoming active drugs such as imipenem-relebactam, cefepime-zidebactam, cefiderocol, and murepavadin. Finally, other therapeutic strategies, such as use of vaccines, antibodies, bacteriocins, anti-quorum sensing, and bacteriophages, are described as future options.
Source: Clinical Microbiology Reviews
DOI: 10.1128/cmr.00031-19
Language: English
Subfield: Molecular Medicine
Domain: Life Sciences
Open Access status: bronze
Funder: Instituto de Salud Carlos III
OpenAlex ID: W2970103499
